Oral Pigmented Lesions: Differential Diagnosis for Dentists and Physicians

How should oral pigmentation be classified at first examination?

Start with pattern rather than colour alone. Separate a solitary lesion from multiple discrete lesions or diffuse pigmentation. Then decide whether the appearance suggests melanin, the natural brown-black pigment; foreign material; blood within vessels; or bleeding into tissue.

Brown, black, blue, purple and red appearances overlap between diagnoses. Deep pigment can appear blue, and a malignant lesion can have little visible pigment. Colour cannot reliably establish either the tissue source or whether a lesion is benign.

The central question is whether the finding has a convincing, stable explanation. A newly noticed lesion is not necessarily newly developed, but uncertainty about its history should lower the threshold for investigation.

• ·Focal, flat pigmentation: melanotic macule, dental-material tattoo, melanocytic naevus or early melanoma.
• ·Focal, raised or nodular change: melanocytic naevus, vascular lesion, melanoma or another tumour.
• ·Diffuse or multifocal pigmentation: physiological variation, exposure-related change, post-inflammatory pigmentation, endocrine disease or an inherited syndrome.
• ·Red-purple discolouration: vascular lesions, trauma-related bleeding or a systemic bleeding disorder.

What history and examination sequence is useful?

Establish when the patient first noticed the lesion and whether photographs or previous dental records show it. Ask about growth, colour change, pain, bleeding and altered sensation. Record dental procedures, trauma, tobacco use, medication exposure, occupational exposures and previous cancers.

Ask about skin or nail changes, fatigue, weight loss, dizziness, abdominal symptoms and family history. Examine the entire mouth under good lighting, not only the reported spot. Include the hard palate, upper gingiva, tongue surfaces and tissues beneath removable appliances.

Measure and photograph the lesion with consent. Record its precise site, symmetry, borders, colours, surface, firmness, mobility and surrounding tissue. Palpate regional lymph nodes and assess mouth opening; perform a focused sensory examination if numbness is reported.

• ·Document whether pigmentation is flat, elevated, ulcerated or associated with a palpable mass.
• ·Compare matching sites on both sides and look for a focal outlier within generalised pigmentation.
• ·Examine accessible skin, lips and nails when relevant; arrange medical assessment for a wider examination.
• ·Do not use absence of pain, tobacco exposure or enlarged lymph nodes to exclude malignancy.

Which focal melanocytic lesions belong in the differential?

A melanotic macule is a flat, circumscribed area of increased melanin. It is often uniform and stable, but appearance alone may not distinguish an intraoral macule from early melanoma. A melanocytic naevus is a local collection of pigment-producing cells; it may be flat or raised and brown or blue.

Oral melanoacanthoma is a benign reactive pigmentation involving pigment-producing cells within the surface lining. It may enlarge quickly, often on the cheek lining. Rapid growth still requires assessment and usually biopsy because a benign reactive diagnosis cannot safely be assumed.

Oral mucosal melanoma is a malignancy of pigment-producing cells. The hard palate and upper gingiva are important sites, but any oral site can be affected. Some melanomas are amelanotic, meaning they lack obvious dark pigment.

• ·Concerning findings include asymmetry, irregular borders, mixed colours, enlargement, nodularity, ulceration or adjacent smaller pigmented spots.
• ·A small or uniformly coloured lesion is not automatically benign.
• ·Skin-based melanoma checklists can support description but are not validated exclusion rules for oral mucosal lesions.
• ·An unexplained new palatal or upper gingival lesion warrants a particularly low threshold for urgent specialist assessment.

When are foreign material, trauma or inflammation plausible explanations?

A dental-material tattoo, often called an amalgam tattoo, results from restorative particles embedded in oral tissue. It commonly appears as a flat blue-grey or black area near previous dental work. A compatible history and visible particles on a targeted dental radiograph support the diagnosis.

The absence of radiographically visible particles does not exclude a tattoo, because deposits may be too small to detect. Conversely, nearby dental treatment does not prove that pigmentation is a tattoo. Uncertain or changing lesions still need specialist assessment and possible biopsy.

Post-inflammatory pigmentation means residual pigment after tissue inflammation or injury. It may occur beside a known inflammatory mucosal disorder. Trauma-related bleeding should have a compatible history and documented resolution rather than remain an indefinite explanation.

• ·Consider other embedded foreign material when there is a credible injury history.
• ·Examine for ongoing inflammation rather than attributing every dark area to an old episode.
• ·Reassess an apparently traumatic lesion if it persists, enlarges or develops a mass.
• ·Avoid cosmetic removal or destructive treatment before the diagnosis is secure.

What causes diffuse or multifocal oral pigmentation?

Physiological pigmentation is normal individual variation, often longstanding and relatively symmetrical. It commonly involves the gingiva. Skin colour alone is insufficient to label a new oral finding physiological, and a changing focal lesion within background pigmentation needs separate assessment.

Tobacco-associated pigmentation and medication-associated pigmentation require a compatible history and distribution. Neither explanation excludes a separate tumour. Document the exposure and communicate with the treating clinician rather than advising independent changes to prescribed care.

Primary adrenal insufficiency, also called Addison disease, can cause diffuse mucosal and skin pigmentation. Associated fatigue, weight loss, dizziness, abdominal symptoms or low blood pressure justify prompt medical assessment. Severe weakness, repeated vomiting, collapse or confusion requires emergency evaluation.

• ·Peutz–Jeghers syndrome: inherited lip and oral pigmentation associated with gastrointestinal polyps and increased cancer risk; refer to gastroenterology and clinical genetics when suspected.
• ·Laugier–Hunziker syndrome: acquired oral or lip pigmentation, sometimes with longitudinal pigmented nail bands; diagnose only after relevant alternatives are assessed.
• ·Exposure-related or systemic pigmentation: use history and examination to guide physician assessment rather than ordering an indiscriminate test panel.
• ·New multifocal pigmentation with systemic symptoms merits coordinated oral medicine and medical review.

How are vascular lesions and bleeding distinguished from pigment?

Vascular lesions contain abnormal or dilated blood vessels and may appear blue or purple. A venous varix is a dilated vein, often seen beneath the tongue or on the lip. Compressibility and blanching with gentle pressure may support a vascular explanation.

Diascopy means observing colour change through a transparent surface during gentle pressure. Blanching suggests blood within compressible vessels, but failure to blanch does not exclude a vascular lesion. Deep location or clotting within the lesion can alter the response.

Petechiae are pinpoint areas of bleeding into tissue; ecchymoses are larger bruises. Unexplained widespread lesions, gingival bleeding or bleeding elsewhere warrant medical assessment. In an immunocompromised patient, unexplained red-purple palatal or gingival lesions also raise concern for conditions such as Kaposi sarcoma, a vascular malignancy.

• ·Do not undertake routine office biopsy of an unexplained compressible, pulsatile or potentially vascular mass.
• ·Pulsation, a palpable vibration or significant bleeding history requires specialist vascular-risk assessment.
• ·Active uncontrolled bleeding or a rapidly expanding swelling requires emergency care.

When is imaging indicated?

Imaging is not routinely needed for every flat pigmented macule and does not replace tissue diagnosis when melanoma is suspected. Select the investigation to answer a specific question about foreign material, vascularity, depth or bone involvement.

A targeted intraoral radiograph may identify restorative particles or adjacent dental disease. Ultrasound with Doppler, which evaluates blood flow, may help assess an accessible suspected vascular lesion. Specialist-selected magnetic resonance imaging can define deeper soft-tissue or vascular extent.

Computed tomography or cone-beam computed tomography may be appropriate when jaw involvement or a bony abnormality is suspected. Cone-beam imaging has limited soft-tissue characterisation and is not a test to exclude mucosal melanoma.

• ·Bone expansion, unexplained tooth mobility, deep fixation or sensory change may justify imaging alongside urgent referral.
• ·Do not wait for imaging before referring a clinically suspicious mucosal lesion.
• ·Cancer staging imaging should be coordinated by the receiving cancer team rather than ordered as a routine pigmentation work-up.

When should an oral pigmented lesion be biopsied?

Biopsy is generally indicated when focal oral pigmentation remains unexplained after examination, particularly when it is new, changing, irregular or located on the palate or upper gingiva. A confidently established stable physiological pattern or dental-material tattoo may not require biopsy, but uncertainty changes that decision.

Suspected melanoma requires prompt tissue diagnosis by a clinician equipped to plan the biopsy and subsequent referral. Incisional biopsy samples part of a lesion; excisional biopsy removes the visible lesion. The choice depends on size, site, vascular risk and suspicion, ideally in discussion with the receiving specialist.

Provide the pathologist with the site, dimensions, duration, changes, clinical differential and photographs where available. Histopathology, the microscopic examination of tissue, may require additional laboratory stains to establish the cell type. A reassuring report that does not fit the clinical findings needs review, not automatic discharge.

• ·Do not wait two weeks to see whether an already suspicious pigmented lesion changes.
• ·Resolve possible vascular risk before biopsy.
• ·Avoid tissue-destroying procedures that prevent adequate pathological assessment.
• ·Light-based adjuncts, surface tests and photographs cannot replace biopsy when tissue diagnosis is indicated.

Exactly when and where should the patient be referred?

Use urgency based on clinical risk, not pigment intensity. Red flags requiring in-person examination include a non-healing ulcer beyond two weeks, a lump, numbness, unexplained bleeding, difficulty opening the mouth or difficulty swallowing. Teleconsultation can support triage but cannot replace palpation or biopsy.

For suspected malignancy, initiate the referral at the assessment visit and communicate the concern directly. Request the earliest urgent appointment rather than placing the patient on a routine review list. If access is delayed, contact another suitable service and track the referral until assessment occurs.

• ·Emergency, same day: uncontrolled bleeding, airway concern, rapidly expanding swelling, inability to swallow fluids, collapse or severe systemic illness. Send to a hospital emergency department.
• ·Urgent cancer assessment: suspected melanoma, a changing irregular pigmented lesion, an associated mass, numbness, suspicious lymph nodes or destructive findings. Refer to oral and maxillofacial surgery or a head-and-neck oncology service with biopsy and pathology access.
• ·Prompt diagnostic assessment: unexplained focal pigmentation without overt cancer features. Refer to oral medicine or oral and maxillofacial surgery; escalate urgently if doubt about malignancy remains.
• ·Possible vascular lesion: refer to oral and maxillofacial surgery or a multidisciplinary vascular-anomalies service before invasive intervention.
• ·Diffuse pigmentation with systemic features: coordinate physician or endocrinology assessment; suspected inherited syndromes need gastroenterology and genetics input.

What does care involve after diagnosis?

Established benign pigmentation may need explanation, baseline documentation and individualised review rather than treatment. Selected benign lesions may be removed for diagnostic, functional or cosmetic reasons by an appropriately trained clinician, after discussing recurrence, scarring and diagnostic certainty.

Reactive pigmentation is managed by addressing the underlying local condition or exposure. Systemic causes require the relevant medical specialty. Vascular lesions may need observation, image-guided intervention or surgery through a team experienced in bleeding-risk management.

Confirmed melanoma requires multidisciplinary head-and-neck cancer care. Options may include surgery, radiotherapy and systemic cancer treatment, selected by the oncology team according to disease extent and patient factors.

In Mumbai and surrounding areas, including Thane and Ambarnath, choose a referral destination with the necessary diagnostic facilities rather than location alone. Send measurements, photographs, relevant imaging and pathology reports, and specify who will communicate results and ensure follow-up.

Which guideline-level principles support these decisions?

The American Dental Association's 2017 evidence-based clinical practice guideline on evaluating potentially malignant disorders in the oral cavity supports immediate biopsy or specialist referral for clinically suspicious lesions. It also supports not substituting adjunctive tests for definitive assessment. This is a general oral-lesion principle, not a dedicated oral melanoma algorithm.

NICE guideline NG12, Suspected cancer: recognition and referral, identifies unexplained oral ulceration lasting more than three weeks and other suspicious oral findings within its referral recommendations. This article uses an ulcer beyond two weeks as an earlier safety-net trigger for examination, not as a quotation of the NICE threshold.

These sources do not provide a complete pigmentation-specific differential or an India-specific referral timetable. The lesion-specific discussion reflects standard oral medicine diagnostic reasoning. Apply local urgent cancer pathways, but do not allow administrative thresholds to delay a clinically suspicious lesion.

• ·Source: American Dental Association, Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity, Journal of the American Dental Association, 2017.
• ·Source: NICE NG12, Suspected cancer: recognition and referral, oral cancer recommendations: https://www.nice.org.uk/guidance/ng12.
• ·Document the working diagnosis, reasons for biopsy or observation, referral urgency and responsibility for reviewing results.